IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,151,068 | +81.2% | 56,032 | -10.5% | 0.00% | +100.0% |
| Q2 2023 | $1,187,408 | +51.9% | 62,594 | +24.2% | 0.00% | 0.0% |
| Q1 2023 | $781,734 | -10.0% | 50,402 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $868,171 | +285.9% | 48,911 | +21.4% | 0.00% | – |
| Q3 2022 | $225,000 | +55.2% | 40,279 | +8.8% | 0.00% | – |
| Q2 2022 | $145,000 | -24.5% | 37,013 | +6.1% | 0.00% | – |
| Q1 2022 | $192,000 | -4.0% | 34,873 | +48.6% | 0.00% | – |
| Q4 2021 | $200,000 | +7.5% | 23,460 | +9.4% | 0.00% | – |
| Q3 2021 | $186,000 | -74.3% | 21,440 | -68.7% | 0.00% | – |
| Q2 2021 | $724,000 | -6.6% | 68,579 | +42.0% | 0.00% | – |
| Q1 2021 | $775,000 | -74.4% | 48,312 | -26.4% | 0.00% | -100.0% |
| Q4 2020 | $3,029,000 | +120.1% | 65,604 | +67.8% | 0.00% | 0.0% |
| Q3 2020 | $1,376,000 | +323.4% | 39,086 | +192.2% | 0.00% | – |
| Q2 2020 | $325,000 | – | 13,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 3,007,000 | $25,620,000 | 3.77% |
| Deep Track Capital, LP | 4,775,000 | $40,683,000 | 2.87% |
| Octagon Capital Advisors LP | 572,862 | $4,881,000 | 0.95% |
| Eventide Asset Management | 4,950,000 | $42,174,000 | 0.54% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,197,000 | 0.44% |
| FRAZIER MANAGEMENT LLC | 585,759 | $4,991,000 | 0.38% |
| MANGROVE PARTNERS IM, LLC | 688,000 | $5,862,000 | 0.35% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $463,000 | 0.31% |
| EcoR1 Capital, LLC | 1,140,819 | $9,720,000 | 0.31% |
| MANGROVE PARTNERS IM, LLC | 570,400 | $4,860,000 | 0.29% |